Fri, April 27, 2018

Vamil Divan Maintained (ABBV) at Hold with Decreased Target to $104 on, Apr 27th, 2018

Vamil Divan of Credit Suisse, Maintained "AbbVie Inc." (ABBV) at Hold with Decreased Target from $109 to $104 on, Apr 27th, 2018.

Vamil has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 2 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018
  • Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Monday, January 29th, 2018


These are the ratings of the 2 analyists that currently disagree with Vamil


  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $80 on, Friday, March 23rd, 2018
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $145 on, Friday, February 2nd, 2018